Teleflex Inc
TFX NYSEΒ· Surgical & Medical Instruments & Apparatus
Last close Β· Oct 26, 2026
$136.80
KIRA Β· Stoqlyβs AI analyst, in plain words
- Teleflex Inc had $2.0B of revenue in fiscal 2025, up 17.2% on the year before. Over five years, revenue changed β4.7% a year on average.
- Its operating margin was 5.9%, down 0.2Β pts: of every 100 in sales, about 6 is left after running the business.
- Teleflex Inc lost $906M in fiscal 2025.
- Free cash flow was $1.4M in fiscal 2025, 0.1% of revenue.
- Teleflex Inc returned $360M to shareholders in fiscal 2025, 24,915% of free cash flow. The diluted share count fell 5.0%.
- Teleflex Inc owes $2.4B more than it holds in cash, about 8.0 years of operating profit.
Market cap
$6.0B
P/E
β
Revenue
$2.0B
Net income
β$906M
Free cash flow
$1.4M
Operating margin
5.9%
Teleflex Inc in 30 seconds Β· fiscal 2025
Are sales growing?
+17.2%
Yes. Sales grew 17.2% last year.
Does it make a profit?
β45.4%
No. It lost money last year.
Does profit turn into cash?
0.1%
Partly. 0.1% of sales ends up as free cash.
Is debt under control?
8.0x
Heavy. Repaying its debt would take 8.0 years of operating profit.
How healthy are the accounts?
5 / 9
Mixed. It passes 5 of 9 health tests.
How is the share priced?
β
No P/E: it made no profit over the last four quarters.
What Teleflex Inc does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 27, 2026
- Legal name
- TELEFLEX INC
- CIK
- 0000096943
Teleflex Inc Β· TFX
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $2.8B | $2.8B | $1.7B | $1.7B | $2.0B |
| Revenue growth | 10.7% | β0.7% | β38.6% | β0.8% | 17.2% |
| Gross margin | 55.2% | 54.9% | 60.7% | 61.0% | 56.2% |
| Operating margin | 22.4% | 17.9% | 15.1% | 6.1% | 5.9% |
| Net income | $485M | $363M | $356M | $69.7M | β$906M |
| Net margin | 17.3% | 13.0% | 20.8% | 4.1% | β45.4% |
| Diluted EPS | $10.23 | $7.68 | $7.53 | $1.48 | β$20.25 |
| Cash | |||||
| Cash from operations | $652M | $343M | $206M | $302M | $96.7M |
| Capital expenditure | $71.6M | $79.2M | $46.4M | $90.4M | $95.2M |
| Free cash flow | $581M | $264M | $160M | $211M | $1.4M |
| FCF margin | 20.7% | 9.4% | 9.3% | 12.4% | 0.1% |
| Dividends paid | $63.6M | $63.8M | $63.9M | $63.5M | $60.3M |
| Share buybacks | β | $0.0M | $0.0M | $200M | $300M |
| Share count change | 0.3% | β0.2% | β0.0% | β0.4% | β5.0% |
| Debt and strength | |||||
| Cash and short-term investments | $445M | $292M | $223M | $248M | $379M |
| Debt incl. finance leases | $2.0B | $1.8B | $1.9B | $1.8B | $2.7B |
| Shareholders' equity | $3.8B | $4.0B | $4.4B | $4.3B | $3.1B |
| Net debt / EBITDA | 1.8x | 2.1x | 4.1x | 5.7x | 8.0x |
| Current ratio | 2.1x | 2.4x | 2.3x | 2.3x | 2.5x |
| Interest coverage | 11.0x | 9.2x | 3.0x | 1.2x | 1.2x |
| Returns and quality | |||||
| Return on capital | 10.3% | 7.4% | 3.3% | 1.8% | 2.2% |
| Return on equity | 13.7% | 9.3% | 8.4% | 1.6% | β24.5% |
| Return on tangible equity | β | β | β | 7.4% | β |
| Piotroski F-score | 7 | 5 | 5 | 7 | 5 |
| Altman Z'' | 4.3 | 4.5 | 4.2 | 4.3 | 3.6 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Teleflex Inc Β· TFX
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $136.80 a share, the company is worth $6.0B.
Source: SEC EDGAR XBRL filings (CIK 0000096943). Data updated October 24, 2026. For information only β not investment advice. Check the original filings before relying on any figure.
